1. Taiwan Stocks

  2. •

    Health technology

  3. •

    Medical specialties
ICARES Medicus Inc

ICARES Medicus Inc

TTPEX:6612
69.40
TWD
-0.20
(-0.29%)
0.63EPS
34.08P/E
3.10BMarket Cap
Nov 18Next Earn
2013 Y
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
TTM
Revenue per Share
0.38
0.58
7.58
7.31
7.18
8.49
10.27
8.82
9.53
12.34
14.37
18.29
24.08
24.99
Basic EPS, GAAP
-1.17
-0.56
0.32
0.57
0.84
1.82
1.98
1.26
1.42
3.11
2.32
2.19
1.09
1.93
Free Cash Flow per Basic Share
-1.83
-1.34
-0.29
0.71
0.99
1.41
-0.14
1.46
0.78
2.29
-2.43
-4.37
-2.39
-1.79
Dividend per Share
- -
- -
- -
- -
- -
0.39
0.41
0.41
0.08
0.41
0.81
0.17
0.28
- -
Book Value per Share
0.19
0.18
1.69
8.24
9.04
14
15.08
16.11
17.94
20.99
33.3
35.03
38.62
40.19
Tangible Book Value per Share
-0.4
-0.08
1.26
7.93
8.79
13.74
12.15
12.09
14.09
18.23
30.82
15.91
21.1
22.69
Basic Weighted Avg Shares
33
13
29
34
37
39
41
41
41
41
42
47
47
48
Sales/Revenue/Turnover
12
8
217
246
266
329
419
363
394
512
605
860
1,131
1,210
Operating Margin (%)
-329.43
-643.73
14.52
16.47
23.88
26.97
28.16
21.32
23.1
24.84
19.6
15.01
11.35
9.52
Depreciation Expense
18
19
20
14
13
11
31
30
29
28
44
89
150
161
Net Income, GAAP
-38
-7
9
19
31
70
81
52
59
129
98
103
51
94
Effective Tax Rate (%)
- -
- -
42.83
54.11
51.72
28.85
37.17
49.94
48.94
22.86
43.13
66.84
95.47
72.93
Profit Margin (%)
-305.83
-95.88
4.21
7.83
11.74
21.4
19.32
14.31
14.88
25.19
16.14
11.99
4.53
7.73
Working Capital
- -
1
93
298
293
479
367
359
441
568
1,169
840
868
908
LT Debt
7
3
135
84
33
3
23
16
9
- -
103
476
230
136
Total Equity
6
6
51
302
337
571
653
702
821
938
1,669
1,763
1,968
1,996
Return on Invested Capital (%)
- -
- -
18.2
6.4
8.02
12.99
10.55
5.58
5.74
10.79
4.52
1.84
0.21
1.17
Return on Capital (%)
- -
- -
0.05
6.9
7.98
14.74
14.99
9.57
10.26
16.59
9.88
7.1
3.65
5.97
Return on Common Equity (%)
- -
-127.87
31.82
10.86
9.78
15.56
13.58
8.05
8.3
15.86
7.96
6.37
2.93
5.35

Capital Structure

TWD

•

in mil. unless spec.
Dec'25
Mar'26
Jun'26
ST Debt
644
619
688
LT Borrowings
110
102
48
LT Finance Leases
120
120
87
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
48
47
47
Market Capitalization
3,192
2,970
3,104

Working Capital

TWD

•

in mil. unless spec.
Dec'25
Mar'26
Jun'26
Total Current Assets
1,701
1,715
1,764
Cash, Cash Equivalents & STI
808
747
793
Accounts Receivable, Net
344
387
367
Inventories
424
450
466
Total Current Liabilities
833
828
856
Payables & Accruals
- -
- -
- -
ST Debt
644
619
688
Deferred Revenue
- -
- -
- -

Growth Rates

TWD

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
72.28%
25.27%
11.66%
Free Cash Flow
-156.98%
-0.67%
-45.28%
Net Income, GAAP
34.13%
12.78%
-50.32%
Sales/Revenue/Turnover
18.94%
26.08%
31.54%
Total Cash Common Dividend
- -
81.84%
65%

Quarterly Revenue

TWD

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
161
185
257
257
860
2025
298
269
264
301
1,131
2026
299
348
- -
- -
- -

Quarterly Earnings Per Share

TWD

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
0.49
0.34
0.71
0.6
2.19
2025
1.01
-0.36
0.05
0.36
1.09
2026
0.81
0.73
- -
- -
- -

Quarterly Dividends Per Share

TWD

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
0.17
2025
- -
- -
- -
- -
0.28
2026
- -
- -
- -
- -
- -

Company Description

Company Profile APIChatGPT
CEO
Yi Hung Le
Full Time Employees
77
Sector
Health technology
Industry
Medical specialties
Address
No. 16, Shengyi Road Hsinchu TP Taiwan 30261
IPO Date
Dec 27, 2016
Website
icaresmedicus.com
Similar Companies
Intuitive Surgical, Inc. (NASDAQ:ISRG)
Boston Scientific Corporation (NYSE:BSX)
Thermo Fisher Scientific Inc (NYSE:TMO)
Illumina, Inc. (NASDAQ:ILMN)
Abbott Laboratories (NYSE:ABT)
GRAIL, Inc. (NASDAQ:GRAL)
Business
ICARES Medicus, Inc. engages in the design, research, development, manufacture, and sale of intraocular lenses and nanomedical devices for ophthalmic applications. The company offers ophthalmic medical devices, including intraocular lenses for the treatment of cataract, myopia, hyperopia, presbyopia, and astigmatism; surgical implant systems; intraocular lens injectors; and related technical services; as well as nanomedical lubricious coatings and various surface treatments for implantable and interventional medical devices. Incorporated in 2011 and headquartered in Zhubei City, Hsinchu County, Taiwan, ICARES Medicus, Inc. operates in Taiwan, the United States, England, Japan, Spain, China, and internationally, with AST Products, Inc. as a subsidiary in Boston. The company listed on the Taipei Exchange in 2018 under ticker 6612.TWO. No major acquisitions, partnerships, funding rounds, new product launches, or strategic shifts have been reported in the last one to two years.